FHCCX | JFNIX | FHCCX / JFNIX | |
Total Expense Ratio | 1.69 | 0.77 | 219% |
Annual Report Gross Expense Ratio | 1.69 | 0.77 | 219% |
Fund Existence | 28 years | 16 years | - |
Gain YTD | -0.462 | 3.176 | -15% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | N/A | 4.49B | - |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | -21.46 | -12.39 | 173% |
Returns for 3 years | -3.22 | 21.30 | -15% |
Returns for 5 years | -18.06 | 8.34 | -216% |
Returns for 10 years | 38.28 | 39.28 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RLUEX | 12.57 | N/A | N/A |
Lazard US Equity Concentrated R6 | |||
FBDIX | 143.61 | N/A | N/A |
Franklin Biotechnology Discovery A | |||
CFSIX | 21.84 | N/A | N/A |
Touchstone Sands Capital Select Growth Y | |||
TIBRX | 31.71 | N/A | N/A |
Thornburg Investment Income Builder R3 | |||
BIRDX | 8.53 | N/A | N/A |
iShares Developed Real Estate Idx Instl |